Vineet Laboratories (BOM:543298) Total Liabilities : ₹821 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Vineet Laboratories Total Liabilities?

Vineet Laboratories's Total Liabilities for the quarter that ended in Mar. 2024 was ₹821 Mil.

Vineet Laboratories's quarterly Total Liabilities declined from Sep. 2023 (₹871.36 Mil) to Dec. 2023 (₹0.00 Mil) but then increased from Dec. 2023 (₹0.00 Mil) to Mar. 2024 (₹821.48 Mil).

Vineet Laboratories's annual Total Liabilities declined from Mar. 2022 (₹1,000.98 Mil) to Mar. 2023 (₹821.66 Mil) and declined from Mar. 2023 (₹821.66 Mil) to Mar. 2024 (₹821.48 Mil).

Vineet Laboratories Total Liabilities Historical Data

The historical data trend for Vineet Laboratories's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vineet Laboratories Total Liabilities Chart

Vineet Laboratories Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Total Liabilities

Get a 7-Day Free Trial

821.27

1,000.98

821.66

821.48

Vineet Laboratories Quarterly Data
	Mar17	Mar18	Mar19	Mar20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial												821.66	758.71	871.36	-	821.48

Vineet Laboratories Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Vineet Laboratories's Total Liabilities for the fiscal year that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	759.963	+	(38.857	+	22.657
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	821

Total Liabilities	=	Total Assets (A: Mar. 2024 )	-	Total Equity (A: Mar. 2024 )
	=	1168.72	-	347.243
	=	821

Vineet Laboratories's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	759.963	+	(38.857	+	22.657
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	821

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	1168.72	-	347.243
	=	821

Vineet Laboratories Total Liabilities Related Terms

Thank you for viewing the detailed overview of Vineet Laboratories's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Vineet Laboratories (BOM:543298) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Vineet Laboratories Ltd (BOM:543298) » Definitions » Total Liabilities

Traded in Other Exchanges

VINEETLAB:India

Address

5-5-160, Malleswari Nilayam, Opposite Vishnu Theatre, Chintalakunta, L.B.Nagar, Hyderabad, TG, IND, 500 074

Website

https://www.vineetlabs.co.in

Vineet Laboratories Ltd Formerly known as Ortin Laboratories Limited, Unit-II is engaged in the business of Pharmaceutical intermediates and Fine chemicals. The products of the companies include Dimethyl phenoxy acetyl chloride, Dimethyl Phenoxy Acetic Acid, Isopropyl-beta-D-thiogalactopyranoside and Nitrophenyl phosphate disodium salt among others. Geographically, the company operates within India and outside India, with a majority of revenue coming from India. The company has one business segment, manufacture of Drug Intermediates & Bulk Dugs.

Vineet Laboratories (BOM:543298) Headlines

No Headlines